USANA Health Sciences Inc (USNA)

Liquidity ratios

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Current ratio 3.52 3.47 3.41 3.04 2.67 2.71 2.56 2.30 2.27 2.33 2.49 2.46 2.53 2.40 2.33 2.30 2.42 2.18 2.71 2.85
Quick ratio 2.84 2.73 2.64 2.27 2.06 1.96 1.72 1.51 1.54 1.57 1.73 1.70 1.90 1.73 1.63 1.56 1.79 1.41 1.82 1.94
Cash ratio 2.78 2.73 2.64 2.27 2.01 1.96 1.72 1.51 1.49 1.57 1.73 1.70 1.86 1.73 1.63 1.56 1.73 1.41 1.82 1.94

The liquidity ratios of USANA Health Sciences Inc show a generally improving trend over the past five quarters. The current ratio has increased from 2.67 in December 2022 to 3.52 in December 2023, indicating the company's ability to meet its short-term obligations has strengthened. Similarly, the quick ratio has shown an upward trend, rising from 2.06 in December 2022 to 2.84 in December 2023, reflecting an improvement in the company's ability to cover its immediate liabilities using its most liquid assets.

The cash ratio has also demonstrated positive movement, increasing from 2.01 in December 2022 to 2.78 in December 2023. This signals that USANA Health Sciences Inc has enhanced its ability to cover its current liabilities solely with its cash and cash equivalents, which is indicative of a strong liquidity position.

Overall, the increasing trend in the company's liquidity ratios suggests an improved ability to handle short-term financial obligations and indicates a healthier liquidity position for USANA Health Sciences Inc.

Additional liquidity measure

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash conversion cycle days 53.73 49.40 50.37 51.01 47.30 44.11 56.77 64.43 64.33 59.66 62.78 76.15 96.41 118.34 112.76 94.81 112.77 129.96 144.00 138.36

The cash conversion cycle is a metric that measures the time it takes for a company to convert its investments in inventory and other resources into cash flows from sales. It provides insight into how efficiently a company manages its working capital.

Looking at the cash conversion cycle of USANA Health Sciences Inc over the past few quarters, we can see some fluctuations in the efficiency of its operations. In the most recent quarter, the company's cash conversion cycle was 53.73 days, which indicates that it took USANA approximately 53.73 days to convert its investments in inventory and other resources into cash flows from sales. This suggests a relatively efficient working capital management compared to the previous quarter, where the cycle was 49.40 days.

Overall, the trend in the cash conversion cycle for USANA Health Sciences Inc has shown some variability, with periods of improvement and deterioration. It is essential for the company to focus on optimizing its inventory management, accounts receivable, and accounts payable processes to keep the cash conversion cycle at a reasonable level and ensure efficient use of its working capital.